Anna Vinogradova

Dental care for HIV+,Hep B and C patients

applying and coordinating implementation of grants
received grant from the United States Agency for International Development(USAID)(2006) and MATRA grant from the Netherlands General Consulate and Ministry of Foreign Affairs(2006-2007)

scholarships to XIV International AIDS Conference, Barcelona, Spain, 2002 and
the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2007), Sydney, Australia,2007


Publications
Abstracts:
-Oral cavity manifestations among HIV patients;
-HIV among women drug users in Drop-in center and Bus for Harm Reduction at XIV International AIDS Conference, July 2002, Barcelona, Spain

-Treatment of oral candidiasis at1st Medical Mycological Congress, February 2003, Moscow, Russia

-Dynamics of epidemic process in St. Petersburg;
-Analysis of HIV-1 gp41 HR1 and HR2 regions of Different genetic forms from Russia and in relation to natural resistance-associated mutations to T-20 and polymorphism at 3rd IAS Conference, July 2005, Rio de Janeiro, Brazil

- Oral manifestations among HIV patients failing antiretroviral therapy at the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2007), Sydney, Australia,2007

Journals:

1. Viral and Bacterial infections in immunocompromised patients “Infections of XXI century"(2001)
2.Oral lesions as a complication of HIV infection in dental scientific-practical journal Parodontology No.4(26) 2001
3. Oral candidiasis among HIV patients with various T(CD4) cells count in Parodontology No.1(26) 2003
4.Analysis of Drug-Resistance Associated Mutations in Treatment-Naïve Individuals Infected with Different Genetic Forms of HIV-1 Circulating in Countries of the Former Soviet Union. Journal of Medical Virology 77:337-344 (2005)

Sector: Health and pharmaceutical

Sector: Health Care and pharmaceutical

Sector: Health and pharmaceutical

Sector: Health Care and pharmaceutical

Sector: Health and pharmaceutical

co-investigator and coordinator in II and III phase clinical trials

Sector: Health Care and pharmaceutical